Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Treatment
69 results:

  • 1. Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.
    Karapetis CS; Liu H; Sorich MJ; Pederson LD; Van Cutsem E; Maughan T; Douillard JY; O'Callaghan CJ; Jonker D; Bokemeyer C; Sobrero A; Cremolini C; Chibaudel B; Zalcberg J; Adams R; Buyse M; Peeters M; Yoshino T; de Gramont A; Shi Q
    Br J Cancer; 2024 May; 130(8):1269-1278. PubMed ID: 38402342
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Circulating miRNAs and lncRNAs serve as biomarkers for early colorectal cancer diagnosis.
    Lotfi E; Kholghi A; Golab F; Mohammadi A; Barati M
    Pathol Res Pract; 2024 Mar; 255():155187. PubMed ID: 38377721
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparative analysis of silver-nanoparticles and whey-encapsulated particles from olive leaf water extracts: Characteristics and biological activity.
    Mansour HMM; Shehata MG; Abdo EM; Sharaf MM; Hafez EE; Galal Darwish AM
    PLoS One; 2023; 18(12):e0296032. PubMed ID: 38109310
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
    Flecchia C; Auclin E; Alouani E; Mercier M; Hollebecque A; Turpin A; Mazard T; Pernot S; Dutherage M; Cohen R; Borg C; Hautefeuille V; Sclafani F; Ben-Abdelghani M; Aparicio T; De La Fouchardière C; Herve C; Perkins G; Heinrich K; Kunzmann V; Gallois C; Guimbaud R; Tougeron D; Taieb J
    Br J Cancer; 2024 Feb; 130(3):442-449. PubMed ID: 38102227
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Adjuvant chemotherapy decision-making in stage II colon adenocarcinoma associated with patients' age and high-risk factors.
    Zheng P; Ye C; Liu H; Gao X; Huang H
    Int J Colorectal Dis; 2023 Dec; 39(1):3. PubMed ID: 38091096
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Adjuvant chemotherapy in patients with clinically node-negative but pathologically node-positive rectal cancer in the Netherlands: A retrospective analysis.
    Kwakman JJM; Bond MJG; Demichelis RM; Koopman M; Hompes R; Elferink MAG; Punt CJA
    Eur J Cancer; 2024 Jan; 197():113466. PubMed ID: 38061213
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Surgical Outcomes in Total Neoadjuvant Therapy for Rectal cancer Versus Standard Long-course Chemoradiation: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lin W; Li C; Clement EA; Brown CJ; Raval MJ; Karimuddin AA; Ghuman A; Phang PT
    Ann Surg; 2024 Apr; 279(4):620-630. PubMed ID: 38009646
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Development of a joint prediction model based on both the radiomics and clinical factors for preoperative prediction of circumferential resection margin in middle-low rectal cancer using T2WI images.
    Ju Y; Zheng L; Qi W; Tian G; Lu Y
    Med Phys; 2024 Apr; 51(4):2563-2577. PubMed ID: 37987563
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response.
    Lee TH; Jang BS; Chang JH; Kim E; Park JH; Chie EK
    Cancer Med; 2023 Jul; 12(14):15664-15675. PubMed ID: 37260182
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A prospective multicentre trial on survival after Microwave Ablation VErsus Resection for Resectable colorectal liver metastases (MAVERRIC).
    Tinguely P; Ruiter SJS; Engstrand J; de Haas RJ; Nilsson H; Candinas D; de Jong KP; Freedman J
    Eur J Cancer; 2023 Jul; 187():65-76. PubMed ID: 37119639
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Deep learning-extracted CT imaging phenotypes predict response to total resection in colorectal cancer.
    Pan X; Cong H; Wang X; Zhang H; Ge Y; Hu S
    Acta Radiol; 2023 May; 64(5):1783-1791. PubMed ID: 36762417
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study.
    Wang J; Xiu J; Farrell A; Baca Y; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Shields AF; Grothey A; Weinberg BA; Marshall JL; Lou E; Khushman M; Sohal DPS; Hall MJ; Liu T; Oberley M; Spetzler D; Korn WM; Shen L; Lenz HJ
    Lancet Oncol; 2023 Feb; 24(2):151-161. PubMed ID: 36681091
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Time-varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population-based study and meta-analysis.
    van der Kruijssen DEW; van der Kuil AJS; Vink GR; Punt CJA; de Wilt JHW; Elias SG; Koopman M
    Int J Cancer; 2023 Apr; 152(7):1360-1369. PubMed ID: 36346099
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Global alteration of colonic microRNAome landscape associated with inflammatory bowel disease.
    Boros É; Hegedűs Z; Kellermayer Z; Balogh P; Nagy I
    Front Immunol; 2022; 13():991346. PubMed ID: 36177008
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Follow-up strategy and survival for five common cancers: A meta-analysis.
    Galjart B; Höppener DJ; Aerts JGJV; Bangma CH; Verhoef C; Grünhagen DJ
    Eur J Cancer; 2022 Oct; 174():185-199. PubMed ID: 36037595
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Microsatellite instability in rectal cancer: what does it mean? A study of two randomized trials and a systematic review of the literature.
    Swets M; Graham Martinez C; van Vliet S; van Tilburg A; Gelderblom H; Marijnen CAM; van de Velde CJH; Nagtegaal ID
    Histopathology; 2022 Sep; 81(3):352-362. PubMed ID: 35758193
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Aspirin colorectal cancer Prevention in Lynch Syndrome: Recommendations in the Era of Precision Medicine.
    Serrano D; Patrignani P; Stigliano V; Turchetti D; Sciallero S; Roviello F; D'Arpino A; Grattagliano I; Testa S; Oliani C; Bertario L; Bonanni B
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328014
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Computed tomography-based radiomics for predicting lymphovascular invasion in rectal cancer.
    Li M; Jin Y; Rui J; Zhang Y; Zhao Y; Huang C; Liu S; Song B
    Eur J Radiol; 2022 Jan; 146():110065. PubMed ID: 34844171
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A meta-analysis of low Hartmann's procedure versus abdominoperineal resection for non-restorative treatment of rectal cancer.
    Ahmad NZ; Azam M; Coffey JC
    Int J Colorectal Dis; 2021 Dec; 36(12):2585-2598. PubMed ID: 34272997
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Circrunx1 functions as an oncogene in colorectal cancer by regulating circrunx1/miR-485-5p/SLC38A1 axis.
    Yu J; Chen X; Li J; Wang F
    Eur J Clin Invest; 2021 Jul; 51(7):e13540. PubMed ID: 33769559
    [TBL] [Abstract] [Full Text] [Related]  


    of 4.